Chemical Pathology 2021

This section of the website is currently for chemical pathology trainees who start specialty training from August 2021.

Chemical Pathology Curriculum 2021

The new 2021 curricula will be assessed by High Level Outcomes, which are included in the form of Capabilities in Practice (CiPs), CiPs describe the professional tasks or work within the scope of postgraduate pathology training; they are based on the format of entrustable professional activities, which are a method of using the professional judgement of appropriately trained assessors as a key aspect of the validity of assessment and a defensible way of forming global judgements of professional performance.

Chemical Pathology Syllabus

This syllabus is an adjunct to the curriculum and is to guide aspects of learning expected to be covered during chemical pathology.

Chemical Pathology Transitional curriculum

For trainees unable to transfer to the 2021 chemical pathology curriculum.

Assessment Strategy

The Royal College of Pathologists' assessment strategy identifies the broad approach and purpose of our programme of assessment and describes the approach for the medical pathology specialties regulated by the General Medical Council.

Workplace Based Assessments

Trainees will be expected to undertaker Supervised Learning Events (SLEs) throughout their specialty training in chemical pathology. Further information on the SLEs and assessment programme can be found in the 2021 chemical pathology curriculum.

CiPs Guidance

The purpose of this guidance is to ensure that trainers and educational supervisors are consistent in their approach to assessing each CiPs. The guidance breaks down each the CiP down into its constituent parts and helps trainers to recognise the minimum level of knowledge, skills and attitudes that should be demonstrated for an entrustment decision to be made. The descriptors and evidence listed are not intended to be comprehensive but guide the trainer and trainee on what satisfactory performance will look like.

The CiP guidance will be available shortly.

ARCP Decision Aid

The year 1 ARCP decision aid will be published shortly.

Chemical Pathology Transitional Arrangements

Transitional Arrangement Webinar

All current trainees not starting their specialty training in August/September 2021 will remain on their current curriculum until after the spring 2022 ARCPs. Existing trainees will be transferred to the new curriculum from the spring after their ARCPs.

Please see below the video and slides from the Transitional Arrangement Webinar held on the 27 April 2022.

Chemical Pathology Transitional Arrangement FAQs

FAQs

If I am on the transitional curriculum and take time out of training for a PhD after ST3, will I return to the transitional curriculum?

The new curriculum has been approved by the GMC, does this mean that the project and critical appraisal is now removed from FRCPath exams?

Is the 31 July 2023 CCT date based on what was used on the previous curriculum? I.e. 5.5 years?

Will there be any resource training to familiarise trainees with the new LEPT system?

What is happening to Stage D requirements? When does your project need to be submitted by on the new curriculum?

If a trainee is not due their ARCP until December this year, will they stay on the current curriculum and using the current LEPT system until after the ARCP in the December?

I am a Chemical Pathology (Metabolic Medicine) trainee, how many clinics do we need to attend across the domain to the new curriculum?

My CCT date is 1 August 2023 – is 31 July 2023 a hard and fast rule?

Will Chemical Pathology only trainees have clinic numbers defined as the same as Chemical Pathology/Metabolic Medicine?

If Chemical Pathology CCT is performed 31 July 2023, do I still need 12 months Stage D after passing the exam? Or can I pass the exam within a few months of CCT?

When will we know whether the project will continue/stop?

Can previous PhD’s be performed before commencing training?